Kevin Hykes bought CVRX once, on Aug 5, 2024

Insider type: Person

Kevin Hykes is the President and Chief Executive Officer of CVRx, Inc., a commercial-stage medical device company focused on neuromodulation therapies for cardiovascular disease, and has served on its Board of Directors since 2022.( He was appointed President and CEO effective February 2024, bringing roughly 30 years of global experience in commercializing novel medical device therapies and leading early- to mid-stage, high-growth companies in neuromodulation and cardiovascular fields.(

Before assuming leadership at CVRx, Hykes served as President and CEO of Augmedics, Inc., an augmented reality surgical navigation company, as well as holding chief executive roles at Bardy Diagnostics, Relievant Medsystems, Metavention, and Cameron Health, and senior commercial leadership roles at Visiogen and Medtronic across cardiac rhythm management, neurostimulation, and cardiac surgery.( In addition to his operating roles, he has been an Operating Partner or Advisor with healthcare investment firms such as Versant Ventures and Revival Healthcare Capital and serves on boards including Metavention and AdvaMed Accel.( Hykes holds a B.A./BBA in Business Administration/Information Systems from the University of Wisconsin and an MBA from Northwestern University’s Kellogg School of Management, underscoring his combination of technical industry expertise and formal business training.(

Written by Perplexity from public sources.